Search Editorial Photos
"Flood absorption"
59 professional editorial images found
#12585784
25 July 2025
A tree-lined pedestrian zone along Nollendorfstrasse in the Schoeneberg district features Gruenderzeit-era apartment buildings and cobblestone paving under a dense green canopy, forming part of the city's climate-adaptive urban structure for heat protection in Berlin, Germany, on July 21, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#12585785
25 July 2025
A tree-lined pedestrian zone along Nollendorfstrasse in the Schoeneberg district features Gruenderzeit-era apartment buildings and cobblestone paving under a dense green canopy, forming part of the city's climate-adaptive urban structure for heat protection in Berlin, Germany, on July 21, 2025.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
Senate hearing on Robert F. Kennedy, Jr.’s nomination to lead Health and Human Services
30 January 2025
#11997224
30 January 2025
Senator Michael Bennet (D-CO) angrily questions Robert F. Kennedy, Jr., Trump's nominee to head Health and Human Services,about his changed stance on abortion during a Senate Finance Committee confirmation hearing in Washington, DC, January 29, 2025. Many of the questions focused on his controversial views on vaccines, fluoride, Covid, stem cells and other issues vital public health.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11104753
29 March 2024
Pro-choice activists march to the Supreme Court before it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. In the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11101298
27 March 2024
Pro-choice demonstrators display a petition signed by more than 500,000 people to maintain FDA approval of the abortion medication mifepristone while the Supreme Court considers ending access to the drug, Washington, DC, March 26, 2024. The Court is hearing oral arguments in the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11101297
27 March 2024
Pro-choice demonstrators display a petition signed by more than 500,000 people to maintain FDA approval of the abortion medication mifepristone while the Supreme Court considers ending access to the drug, Washington, DC, March 26, 2024. The Court is hearing oral arguments in the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11101095
27 March 2024
Pro-choice activists march in front of the Supreme Court before it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. In the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11101094
27 March 2024
Kansas Attorney General Kris Kobach speaks in against access to abortion medication mifepristone following oral arguments Food and Drug Administration v. Alliance for Hippocratic Medicine, a case that could end access to the medication, Washington, DC, March 26, 2024. AHM asked the Court to curtail access to mifepristone, which has been in use in the U.S. for 24 years. The Southern Poverty Law Center has designated Alliance Defending Freedom as a hate group.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11101092
27 March 2024
Pro-choice and anti-abortion activists demonstrate at the Supreme Court as it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. The Court hears oral arguments today in the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11100933
27 March 2024
Pro-choice activists demonstrate outside the Supreme Court before it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. In the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11100846
27 March 2024
A pregnant anti-abortion activist partcipates in a demonstration at the Supreme Court as it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. In the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11100830
27 March 2024
An anti-abortion activist lies 'dead' on the ground during a demonstration at the Supreme Court as it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. In the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11100739
26 March 2024
An anti-abortion activist dressed as the Grim Reaper demonstrates at the Supreme Court before it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. In the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11100613
26 March 2024
One of hundreds of pro-choice activists demonstrates outside the Supreme Court before it hears oral arguments in a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. In the case, Food and Drug Administration v. Alliance for Hippocratic Medicine, in which AHM is challenging FDA's approval of mifepristone in 2000. More than half of abortions in the U.S. are by medication.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11100567
26 March 2024
Erin Hawley, Senior Counsel of Alliance Defending Freedom, speaks to the press following oral arguments Food and Drug Administration v. Alliance for Hippocratic Medicine, a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. Hawley and AHM asked the Court to curtail access to mifepristone, which has been in use in the U.S. for 24 years. The Southern Poverty Law Center has designated Alliance Defending Freedom as a hate group.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.
#11100541
26 March 2024
Erin Hawley, Senior Counsel of Alliance Defending Freedom, speaks to the press following oral arguments Food and Drug Administration v. Alliance for Hippocratic Medicine, a case that could end access to the abortion medication mifepristone, Washington, DC, March 26, 2024. Hawley and AHM asked the Court to curtail access to mifepristone, which has been in use in the U.S. for 24 years. The Southern Poverty Law Center has designated Alliance Defending Freedom as a hate group.
Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.